Bayforest Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.5K Buy
+103
New +$15.3K 0.02% 789
2026
Q1
Sell
-2,193
Closed -$176K 882
2025
Q4
$176K Sell
2,193
-3,922
-64% -$328K 0.13% 320
2025
Q3
$597K Buy
6,115
+1,898
+45% +$153K 0.28% 94
2025
Q2
$294K Buy
4,217
+3,453
+452% +$197K 0.13% 303
2025
Q1
$37.9K Buy
+764
New +$48.3K 0.02% 589

Other funds holding ACLS

Bayforest Capital's ACLS Position: Q2 2026 in Review

Bayforest Capital opened a new position in Axcelis (ACLS) in Q2 2026: 103 shares worth $19.5K. The stake represents 0.02% of the portfolio and ranks #789 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in ACLS as recently as Q4 2025.

Bayforest Capital first reported a position in ACLS in Q1 2025 and has held it in 5 quarters since. The position peaked at $597K in Q3 2025. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Bayforest Capital held 103 shares of Axcelis worth $19.5K as of Q2 2026.
  • Axcelis was a new Bayforest Capital position in Q2 2026.
  • Axcelis made up 0.02% of Bayforest Capital's portfolio in Q2 2026, its #789 holding.
  • Bayforest Capital first reported a position in Axcelis in Q1 2025 and has held it in 5 quarters since.
  • Bayforest Capital's Axcelis position peaked at $597K in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.